Managed health care company Magellan Health, Inc., a subsidiary of Centene (NYSE:CNC), announced on Thursday that it has introduced a Teen Mental Wellbeing app aimed at supporting individuals aged 13-22.
Powered by BeMe Health's digital platform, the app offers evidence-based tools to enhance self-awareness, resilience and mental health.
Designed for use on mobile devices, it provides real-time content tailored to users' moods, skill-building activities and personalized coaching via chat. Clinically validated screenings, including for depression and anxiety, help triage participants to appropriate interventions.
Users have 24/7 access to crisis support and can be referred to virtual therapy sessions through Magellan's employee assistance program.
Abbott receives CE Mark for Volt Pulsed Field Ablation System to treat atrial fibrillation
Vast Therapeutics' ALX1 drug candidate granted QIDP designation by US FDA
Qlife secures UK approval to initiate clinical trial for Egoo Phe System
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
Femasys receives CE mark approval for FemBloc delivery system in Europe
Avance Biosciences registers with CLIA program
Abbott announces quarterly common dividend
Aiforia secures IVDR certification for expanded AI-powered cancer diagnostics in Europe
Limaca Medical launches Precision-GI endoscopic automated motorised EUS biopsy device in US
Owens & Minor launches ByramConnect digital health platform for diabetes management
Acrivon Therapeutics receives FDA Breakthrough Device designation for ACR-368 OncoSignature assay
BrainCool secures market approval for BrainCool System in Malaysia
Bioretec Ltd secures CE mark approval for RemeOs Trauma Screw portfolio
Biohit launches FAEX Sample System for stool sample collection